Free Trial

scPharmaceuticals (SCPH) News Today

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)
Free SCPH Stock Alerts
$3.75
-0.13 (-3.35%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 9 at 11:55 AM | marketbeat.com
Rubric Capital Management LP Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)
Rubric Capital Management LP lifted its stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 29.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,500,000 shares of the company's stock after buying an addit
May 29, 2024 | globenewswire.com
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 27, 2024 | marketbeat.com
scPharmaceuticals Inc. (NASDAQ:SCPH) is AIGH Capital Management LLC's 2nd Largest Position
AIGH Capital Management LLC lifted its position in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 40.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,106,795 shares of the company's stock after a
May 22, 2024 | marketbeat.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by King Luther Capital Management Corp
King Luther Capital Management Corp raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 48.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,393,525 shares of the company's stock after buying an additi
May 20, 2024 | marketbeat.com
scPharmaceuticals Inc. (NASDAQ:SCPH) is Worth Venture Partners LLC's 8th Largest Position
Worth Venture Partners LLC increased its stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 42.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 771,344 shares of the
May 17, 2024 | marketbeat.com
Q2 2024 EPS Estimates for scPharmaceuticals Inc. Lowered by Analyst (NASDAQ:SCPH)
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Research analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of scPharmaceuticals in a report released on Wednesday, May 15th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0
May 16, 2024 | benzinga.com
scPharmaceuticals Stock (NASDAQ:SCPH), Analyst Ratings, Price Targets, Predictions
May 16, 2024 | markets.businessinsider.com
Furoscix Growth Prospects Anchor Buy Rating for scPharmaceuticals
May 16, 2024 | marketbeat.com
FY2027 Earnings Estimate for scPharmaceuticals Inc. (NASDAQ:SCPH) Issued By HC Wainwright
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Equities research analysts at HC Wainwright dropped their FY2027 EPS estimates for scPharmaceuticals in a research report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of
May 15, 2024 | finance.yahoo.com
Q1 2024 scPharmaceuticals Inc Earnings Call
May 15, 2024 | marketbeat.com
scPharmaceuticals (NASDAQ:SCPH) Releases Earnings Results, Beats Estimates By $0.09 EPS
scPharmaceuticals (NASDAQ:SCPH - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.45) by $0.09. scPharmaceuticals had a negative return on equity of 97.18% and a negative net margin of 403.22%. The firm had revenue of $6.10 million during the quarter, compared to the consensus estimate of $6.50 million. During the same period in the prior year, the company earned ($0.30) EPS.
May 15, 2024 | marketbeat.com
scPharmaceuticals' (SCPH) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $18.00 target price on shares of scPharmaceuticals in a research note on Wednesday.
May 15, 2024 | finanznachrichten.de
scPharmaceuticals, Inc.: scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024 | msn.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
May 15, 2024 | markets.businessinsider.com
Buy Rating Affirmed for scPharmaceuticals Amid Furoscix Success and Market Expansion
May 15, 2024 | finance.yahoo.com
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
May 14, 2024 | seekingalpha.com
Kingstone Companies, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 14, 2024 | investorplace.com
SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 14, 2024 | msn.com
Stocks See Support as Bond Yields Fall on Powell Comments
May 14, 2024 | globenewswire.com
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024 | markets.businessinsider.com
What Wall Street expects from scPharmaceuticals's earnings
May 13, 2024 | msn.com
scPharmaceuticals Q1 2024 Earnings Preview
May 13, 2024 | finance.yahoo.com
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024 | globenewswire.com
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 8, 2024 | marketbeat.com
scPharmaceuticals (SCPH) to Release Quarterly Earnings on Tuesday
scPharmaceuticals (NASDAQ:SCPH) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports.
May 7, 2024 | globenewswire.com
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
April 24, 2024 | finance.yahoo.com
scPharmaceuticals Inc. (SCPH) Interactive Stock Chart - Yahoo Finance
April 24, 2024 | markets.businessinsider.com
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
April 24, 2024 | globenewswire.com
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
April 18, 2024 | marketbeat.com
scPharmaceuticals (NASDAQ:SCPH) Stock Price Down 5.4%
scPharmaceuticals (NASDAQ:SCPH) Shares Down 5.4%
April 10, 2024 | msn.com
Novel Biannual Antihypertensive Shows Potential for Combination Therapy
March 27, 2024 | finance.yahoo.com
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
March 20, 2024 | finanznachrichten.de
scPharmaceuticals, Inc.: scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 18, 2024 | marketbeat.com
HC Wainwright Reaffirms Buy Rating for scPharmaceuticals (NASDAQ:SCPH)
HC Wainwright reaffirmed a "buy" rating and set a $18.00 target price on shares of scPharmaceuticals in a research report on Thursday.
March 16, 2024 | insidermonkey.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
March 16, 2024 | finance.yahoo.com
SCPH Apr 2024 5.000 put
March 15, 2024 | markets.businessinsider.com
Buy Rating Affirmed for scPharmaceuticals Amidst Revenue Surge and Solid Financial Footing
March 14, 2024 | finance.yahoo.com
Q4 2023 scPharmaceuticals Inc Earnings Call
March 14, 2024 | markets.businessinsider.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Jazz Pharmaceuticals (JAZZ) and scPharmaceuticals (SCPH)
March 14, 2024 | markets.businessinsider.com
Strong Buy Recommendation for scPharmaceuticals on Furoscix’s Successful Launch and Growth Prospects
March 13, 2024 | finance.yahoo.com
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
March 13, 2024 | globenewswire.com
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 12, 2024 | msn.com
scPharmaceuticals Q4 2023 Earnings Preview
March 11, 2024 | markets.businessinsider.com
Craig-Hallum Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)
March 9, 2024 | markets.businessinsider.com
scPharmaceuticals Inc Registered Shs hosts conference call for investors
March 7, 2024 | marketbeat.com
scPharmaceuticals (SCPH) Set to Announce Earnings on Wednesday
scPharmaceuticals (NASDAQ:SCPH) will be releasing earnings after the market closes on Wednesday, March 13, Zacks reports.
March 6, 2024 | globenewswire.com
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
February 28, 2024 | globenewswire.com
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
February 21, 2024 | benzinga.com
scPharmaceuticals Stock (NASDAQ:SCPH), Short Interest Report
February 16, 2024 | marketbeat.com
Tejara Capital Ltd Invests $722,000 in scPharmaceuticals Inc. (NASDAQ:SCPH)
Tejara Capital Ltd acquired a new stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 101,414 shares of the company's stock, valued at approximately $722,000.
Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

Top 5 AI Stocks to Buy for 2024 (Ad)

The electric vehicle boom is accelerating – and fast.

Click to View The 5 Best AI Stocks to Invest In

SCPH Media Mentions By Week

SCPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCPH
News Sentiment
▼
1.54

0.76
▲
Average
Medical
News Sentiment

SCPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCPH Articles
This Week
▼
1

1
▲
SCPH Articles
Average Week

Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SCPH) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored
Biden Nomination CANCELED?
And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...
The Freeport Society | Sponsored
Jeff Bezos & 48 Members of Congress Are Buying ONE Sector…
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...
InvestorPlace | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored